Search

Heron Therapeutics Inc

Suletud

SektorTervishoid

0.4 11.11

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.39

Max

0.41

Põhinäitajad

By Trading Economics

Sissetulek

2.6M

-5.5M

Müük

3M

38M

Aktsiakasum

-0.03

Kasumimarginaal

-14.573

Töötajad

128

EBITDA

2.1M

-5.5M

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-27M

70M

Eelmine avamishind

-10.71

Eelmine sulgemishind

0.4

Heron Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. okt 2026, 00:01 UTC

News

Mesa Laboratories Inc announced a quarterly dividend of $0.16 per share, with a record date of November 30, 2026, and payment on December 15, 2026.

9. okt 2026, 23:50 UTC

News

Constellation Brands Inc shares are modestly higher in after-market trading as analysts assess the company's valuation amid its focus on beer, wine, and spirits.

9. okt 2026, 23:25 UTC

News

Aon PLC declared a quarterly dividend of $0.820 per share, payable on November 13, 2026, and confirmed third-quarter earnings release for October 28, 2026.

9. okt 2026, 23:15 UTC

News

PayPal Holdings Inc is trading lower in after-hours activity, focusing on expanding credit offerings and Buy Now Pay Later services while planning share buybacks.

9. okt 2026, 23:15 UTC

News

Coca-Cola Consolidated Inc. declared a quarterly dividend of $0.25 per share, payable on November 6, 2026, to shareholders on record as of October 23, 2026.

9. okt 2026, 23:10 UTC

News

EnerSys receives a strong buy designation from Wall Street analysts, driven by optimism about AI infrastructure's impact on the data center sector.

9. okt 2026, 23:05 UTC

News

Truist Financial announces a $250K grant to support Gulf Coast communities' relief and recovery efforts ahead of Hurricane Isaias.

9. okt 2026, 23:05 UTC

News

JP Morgan reaffirms Overweight rating on Parker-Hannifin Corp, lowering its price target to $1.13K in a report released after the market closed.

9. okt 2026, 23:05 UTC

News

DICK'S Sporting Goods faces two class action lawsuits alleging securities fraud related to its business performance and disappointing financial results.

9. okt 2026, 23:01 UTC

News

Royal Caribbean Cruises Ltd is trading modestly lower in after-market hours, continuing a downward trend despite analysts suggesting the stock may be undervalued.

9. okt 2026, 23:01 UTC

Social Media
News

Perrigo Company PLC is reportedly under renewed takeover interest from an unidentified buyer, with speculation that CVC Capital may pursue an acquisition.

9. okt 2026, 23:01 UTC

News

Delta Air Lines Inc cut its guidance after missing third-quarter earnings and revenue estimates, with shares trading modestly lower in after-market hours.

9. okt 2026, 23:01 UTC

News
Social Media

Verizon shares are trading higher in after-market hours, despite reports of its worst trading day since 2002 amid competitive pressures from SPCX and T-Mobile's decline.

9. okt 2026, 22:50 UTC

News
Social Media

Star Bulk Carriers announces a partnership with Hermes World Maritime and renews equity offerings with Deutsche Bank for $41.37M and Jefferies for $75M.

9. okt 2026, 22:50 UTC

News

GoDaddy faces a class action lawsuit from Pomerantz LLP alleging securities fraud and unlawful business practices, encouraging affected shareholders to join by October 20, 2026.

9. okt 2026, 22:21 UTC

News

CareTrust REIT, Inc. released its sixth annual Corporate Sustainability Report, highlighting advancements in sustainability initiatives and adherence to ISS ESG Prime status.

9. okt 2026, 22:20 UTC

News

Mesa Laboratories Inc announced a quarterly dividend of $0.16 per share, payable on December 15, 2026, to shareholders of record on November 30, 2026.

9. okt 2026, 21:01 UTC

Correlated Moves
News

USD/PLN is gaining and remains above its 20-day moving average, near the upper end of its one-month range, despite earlier pulling back from a session high.

9. okt 2026, 20:41 UTC

News
Correlated Moves

USD/SEK is modestly higher, supported by an increase in the U.S. Baker Hughes total rig count to 603 from 598.

9. okt 2026, 20:40 UTC

News

Standard Motor Products announces CFO Nathan R. Iles' resignation effective October 30, 2026, with James J. Burke as interim CFO, prompting a decline in after-market trading.

9. okt 2026, 20:07 UTC

News

United Parcel Service Inc shares are higher, supported by plans to hire 100k seasonal workers and new services aimed at enhancing parcel security and pricing power.

9. okt 2026, 20:07 UTC

News
Correlated Moves
Social Media

Microsoft introduces its new AI model, Microsoft-Decision-1, which reportedly makes decisions 35 times faster than OpenAI's GPT-6 Sol, as announced by CEO Satya Nadella.

9. okt 2026, 20:07 UTC

News

Baird analyst Andrew Wittmann lowered Construction Partners Inc's price target to $115.00 from $141.00 while maintaining an Outperform rating.

9. okt 2026, 20:07 UTC

News

Barclays analyst Michael Lonegan lowers Idacorp's price target to $149.00 from $162.00 while maintaining an Overweight rating.

9. okt 2026, 20:07 UTC

Macro Event
News

Evercore ISI maintains its Underperform rating on Franklin Resources, lowering the price target to $35, contributing to a decline in the stock.

9. okt 2026, 20:07 UTC

Macro Event
News

Dollar General shares advanced, buoyed by broader market gains, despite earlier pulling back from a session high, amid a significant drop in consumer sentiment.

9. okt 2026, 20:07 UTC

News

UBS reaffirms Buy rating on Biogen Inc and raises price target to $270 from $240, while CCB International initiates coverage with an Outperform rating.

9. okt 2026, 20:07 UTC

Correlated Moves
News
Social Media

Viking Therapeutics is seeing increased interest amid reports of a potential bidding war, with speculation about suitors including LLY and positive momentum in the biotech sector.

9. okt 2026, 20:07 UTC

News

Schrodinger Inc rebounds amid volatility, supported by a $1.8 billion Biohub partnership announced by the White House focusing on AI-ready biological data.

9. okt 2026, 20:07 UTC

Social Media
News

Raymond James initiated coverage on Kymera Therapeutics Inc with an Outperform rating and set a price target of $140.

Võrdlus sarnastega

Hinnamuutus

Heron Therapeutics Inc Prognoos

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.